(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture...
Stats | |
---|---|
Šios dienos apimtis | 12 466.00 |
Vidutinė apimtis | 11 339.00 |
Rinkos kapitalizacija | 0.00 |
EPS | $0.0271 ( 2022-01-30 ) |
Last Dividend | $0.656 ( 2021-03-12 ) |
Next Dividend | $0 ( N/A ) |
P/E | -6 265.00 |
ATR14 | $0 (0.00%) |
Avid Bioservices, Inc. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
RCON | 0.899 |
ARHS | 0.896 |
UBFO | 0.893 |
SRAX | 0.878 |
FSBW | 0.876 |
BCML | 0.876 |
CGBD | 0.874 |
CVLY | 0.872 |
KBWB | 0.87 |
EWBC | 0.87 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
CNST | -0.888 |
ANGI | -0.883 |
EPZM | -0.877 |
DDOG | -0.872 |
LFVN | -0.861 |
LASR | -0.861 |
IOVA | -0.855 |
FLGT | -0.854 |
DMRC | -0.852 |
ANIP | -0.851 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Avid Bioservices, Inc. Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $149.27M |
Bruto pelnas: | $31.48M (21.09 %) |
EPS: | $0.00900 |
FY | 2023 |
Pajamos: | $149.27M |
Bruto pelnas: | $31.48M (21.09 %) |
EPS: | $0.00900 |
FY | 2022 |
Pajamos: | $119.60M |
Bruto pelnas: | $36.65M (30.64 %) |
EPS: | $2.08 |
FY | 2021 |
Pajamos: | $95.87M |
Bruto pelnas: | $29.31M (30.57 %) |
EPS: | $0.198 |
Financial Reports:
No articles found.
Avid Bioservices, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.299 | 2014-03-19 |
Last Dividend | $0.656 | 2021-03-12 |
Next Dividend | $0 | N/A |
Payout Date | 2021-04-01 | |
Next Payout Date | N/A | |
# dividends | 29 | -- |
Total Paid Out | $18.67 | -- |
Avg. Dividend % Per Year | 1.06% | -- |
Score | 2.21 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0.0723 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $2.62 | 14.70% |
2019 | $2.62 | 12.90% |
2020 | $2.62 | 11.10% |
2021 | $0.656 | 2.40% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.131 | 1.500 | -2.62 | -3.93 | [0 - 0.5] |
returnOnAssetsTTM | -0.0394 | 1.200 | -1.312 | -1.574 | [0 - 0.3] |
returnOnEquityTTM | -0.0963 | 1.500 | -2.18 | -3.27 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.465 | 0.800 | -2.68 | -2.14 | [1 - 3] |
quickRatioTTM | 0.297 | 0.800 | -2.96 | -2.37 | [0.8 - 2.5] |
cashRatioTTM | 0.138 | 1.500 | -0.346 | -0.519 | [0.2 - 2] |
debtRatioTTM | 0.431 | -1.500 | 2.81 | -4.22 | [0 - 0.6] |
interestCoverageTTM | -10.85 | 1.000 | -5.13 | -5.13 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.194 | 2.00 | 9.94 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.608 | 2.00 | -0.304 | -0.608 | [0 - 20] |
debtEquityRatioTTM | 1.090 | -1.500 | 5.64 | -8.46 | [0 - 2.5] |
grossProfitMarginTTM | 0.0747 | 1.000 | -2.09 | -2.09 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.132 | 1.000 | -4.64 | -4.64 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0627 | 1.000 | -0.763 | -0.763 | [0.2 - 2] |
assetTurnoverTTM | 0.300 | 0.800 | -1.331 | -1.065 | [0.5 - 2] |
Total Score | -0.942 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -25.98 | 1.000 | -2.72 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0963 | 2.50 | -1.402 | -3.27 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.608 | 2.00 | -0.203 | -0.608 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.194 | 2.00 | 9.94 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.261 | 1.500 | -1.594 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0900 | 1.000 | -0.250 | 0 | [0.1 - 0.5] |
Total Score | 0.0723 |
Avid Bioservices, Inc.
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.